Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Sector: Healthcare; Industry: Biotechnology

BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2019-05-24 Wegman Mark N Director Sell 7,800 $61.09 $476,502 No
2019-05-22 Wegman Mark N Director Sell 1,200 $63.70 $76,440 No
2019-05-21 Wegman Mark N Director Sell 6,000 $64.04 $384,236 No
2018-09-11 Wegman Mark N Director Sell 6,500 $57.52 $373,861 No
2018-08-23 Wegman Mark N Director Sell 8,500 $52.63 $447,322 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.